Key regions: United States, Germany, Australia, India, United Kingdom
The Sleep Aids (Pharmacies) market in G7 countries has been experiencing significant growth in recent years. This can be attributed to several factors, including changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.
Customer preferences: One of the main reasons behind the growth of the Sleep Aids (Pharmacies) market in G7 countries is the changing preferences of customers. With the increasing prevalence of sleep disorders and the growing awareness about the importance of good sleep, consumers are actively seeking solutions to improve their sleep quality. This has led to a rise in the demand for sleep aids, such as over-the-counter sleep medications and natural sleep remedies.
Trends in the market: Several trends have emerged in the Sleep Aids (Pharmacies) market in G7 countries. One of the key trends is the shift towards natural and herbal sleep aids. Consumers are becoming more conscious about the potential side effects of traditional sleep medications and are opting for natural alternatives. This has led to the introduction of a wide range of herbal sleep aids in the market, including supplements and teas. Another trend in the market is the increasing availability of sleep aids in pharmacies. Pharmacies are expanding their product offerings to cater to the growing demand for sleep aids. They are stocking a variety of sleep medications, supplements, and other products to provide customers with a wide range of options. This has made it more convenient for consumers to access sleep aids and has contributed to the overall growth of the market.
Local special circumstances: Each G7 country has its own set of local special circumstances that influence the Sleep Aids (Pharmacies) market. For example, in the United States, the market is highly regulated, with strict guidelines for the sale and distribution of sleep aids. This has led to the dominance of prescription sleep medications in the market. On the other hand, in countries like Japan and Germany, there is a strong preference for natural and herbal sleep aids, leading to the availability of a wide range of such products in pharmacies.
Underlying macroeconomic factors: The growth of the Sleep Aids (Pharmacies) market in G7 countries is also influenced by underlying macroeconomic factors. Factors such as rising disposable incomes, increasing healthcare expenditure, and aging populations contribute to the growth of the market. As people become more financially capable, they are willing to spend on sleep aids to improve their sleep quality. Additionally, the aging population in many G7 countries is more prone to sleep disorders, leading to a higher demand for sleep aids. In conclusion, the Sleep Aids (Pharmacies) market in G7 countries is experiencing significant growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for sleep aids is driven by the increasing prevalence of sleep disorders and the growing awareness of the importance of good sleep. As a result, pharmacies are expanding their product offerings to cater to the rising demand, and consumers are opting for natural and herbal sleep aids. The market is also influenced by local regulations and macroeconomic factors such as rising disposable incomes and aging populations.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
